NTI 2.94% 7.0¢ neurotech international limited

Ann: Preclinical Success with Targeted Combination Therapies, page-20

  1. 4,387 Posts.
    lightbulb Created with Sketch. 8497
    @glory

    i think it'll wake up pretty quick once a bit of news arrives

    NTI164 increases Diclofenac efficacy resulting in a Tumor Necrotic Factor - alpha expression reduction of 63% and same same 80% reduction for Interleukin 6 .....these are stunning numbers ....globally.... in the reduction of inflammatory response ...and includes the potential mitigation of Diclofenac side effects ....looking forward to the news

    add to that the potential to treat other neuro degenerative conditions such as Alzheimer's and TBI and its looking pretty good right now.

    glah
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
0.002(2.94%)
Mkt cap ! $71.23M
Open High Low Value Volume
6.9¢ 7.3¢ 6.9¢ $126.7K 1.791M

Buyers (Bids)

No. Vol. Price($)
2 43931 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 200000 1
View Market Depth
Last trade - 15.55pm 09/09/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.